Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 CAD | +0.39% | -1.53% | +49.42% |
16/04 | North American Morning Briefing : Powell Comments, -2- | DJ |
15/04 | Alliance Global Upgrades OrganiGram Holdings to Buy From Neutral | MT |
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 61% by 2026.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- Low profitability weakens the company.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+49.42% | 194M | C | ||
+31.96% | 272M | - | ||
+33.74% | 261M | - | ||
+44.98% | 131M | - | ||
-28.57% | 121M | - | - | |
+115.91% | 119M | - | - | |
-42.17% | 119M | C | ||
0.00% | 86.82M | - | - | |
+150.00% | 75.33M | - | - | |
+1.20% | 55.24M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- OGI Stock
- Ratings Organigram Holdings Inc.